How an unsolicited offer led to 11th-hour bids and the biggest Bay Area biotech deal of the year

Longtime CEO Ted Love could gross nearly $26 million in severance cash, benefits and equity in the deal, but the biggest winners are institutional money managers that will reap $1.95 billion from cashing in their stock.